GBFH vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

GBFH

36.6
AI Score
VS
CARE Wins

CARE

66.6
AI Score

Investment Advisor Scores

GBFH

37score
Recommendation
AVOID NEW MONEY

CARE

67score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GBFH CARE Winner
Forward P/E 13.9276 13.6612 CARE
PEG Ratio 0 0 Tie
Revenue Growth 14.5% 68.3% CARE
Earnings Growth 14.4% 253.9% CARE
Tradestie Score 36.6/100 66.6/100 CARE
Profit Margin 24.5% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD CARE

Relative Price Performance (Last 90 Days)

GBFH 1M: -9.6% · 3M: -42.9% CARE 1M: -2.7% · 3M: -7.4%

Current Technical Phase

GBFH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.1%), weak momentum, RSI 29

RSI (14): 29.0 · Price: $17.93

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $30.75

Fundamentals Snapshot

Metric GBFH CARE
Market Cap — —
Forward P/E 6.8 11.8
Trailing P/E 14.2 5.2
Revenue (TTM) — —
Revenue Growth 0.1% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.6%
EPS 1.25 5.89
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.